Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
Droplet digital PCR detects BRAF allele fraction in ctDNA with high reproducibility and sensitivity, offering an alternative to NGS
Evidence for efficacy is based on the results from the Study CDRB436G2201
Findings from the NEOSTAR phase II platform study
Findings from a large comprehensive analysis do not support the evidence of a common genetic clonal alteration
Findings from the ProtecT study after 15 years of follow-up
Findings from the DeFi study
DNA sequencing findings among patients with acute myeloid leukaemia in first remission prior to allogeneic haematopoietic cell transplant
Evidence for efficacy is based on the results from the monarchE study
Health-Related Quality-of-Life data from the KEYNOTE-826 study
First proof of genomics-based precision medicine for a chemotherapy in metastatic colorectal cancer
Findings from an analytical modelling study
It is indicated with prednisone or prednisolone for the treatment of metastatic castration-resistant prostate cancer with BRCA1/2 mutations
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.
